Literature DB >> 16434662

Surviving glioblastoma for more than 5 years: the patient's perspective.

J P Steinbach1, H-P Blaicher, U Herrlinger, W Wick, T Nägele, R Meyermann, M Tatagiba, M Bamberg, J Dichgans, H-O Karnath, M Weller.   

Abstract

The authors performed a comprehensive analysis of the functional outcome of 10 patients who had survived 5 years from a diagnosis of glioblastoma. Neurologic deficits were mild in most patients, but neuropsychological testing demonstrated cognitive deficits in all patients. Depression and anxiety were common. Although most patients thought that their social functioning and work ability were impaired, little reduction in overall quality of life was perceived.

Entities:  

Mesh:

Year:  2006        PMID: 16434662     DOI: 10.1212/01.wnl.0000194221.89948.a0

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  31 in total

Review 1.  [Neurological complications of neurooncological therapy].

Authors:  U Herrlinger; J P Steinbach
Journal:  Nervenarzt       Date:  2010-08       Impact factor: 1.214

2.  Neurocognitive and sociodemographic functioning of glioblastoma long-term survivors.

Authors:  Birgit Flechl; Michael Ackerl; Cornelia Sax; Karin Dieckmann; Richard Crevenna; Alexander Gaiger; Georg Widhalm; Matthias Preusser; Christine Marosi
Journal:  J Neurooncol       Date:  2012-05-29       Impact factor: 4.130

3.  Very late relapses in glioblastoma long-term survivors.

Authors:  Oliver Bähr; Ulrich Herrlinger; Michael Weller; Joachim P Steinbach
Journal:  J Neurol       Date:  2009-05-12       Impact factor: 4.849

Review 4.  Life beyond a diagnosis of glioblastoma: a systematic review of the literature.

Authors:  L Gately; S A McLachlan; A Dowling; J Philip
Journal:  J Cancer Surviv       Date:  2017-02-13       Impact factor: 4.442

5.  Glioblastoma multiforme: Molecular characterization and current treatment strategy (Review).

Authors:  Xiang Zhang; Wei Zhang; Wei-Dong Cao; Gang Cheng; Yong-Qiang Zhang
Journal:  Exp Ther Med       Date:  2011-10-18       Impact factor: 2.447

Review 6.  Depression and glioblastoma, complicated concomitant diseases: a systemic review of published literature.

Authors:  Luke Mugge; Tarek R Mansour; Megan Crippen; Yasaman Alam; Jason Schroeder
Journal:  Neurosurg Rev       Date:  2018-08-09       Impact factor: 3.042

7.  Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed?

Authors:  Michela Buglione; Sara Pedretti; Pietro Luigi Poliani; Roberto Liserre; Stefano Gipponi; Giannantonio Spena; Paolo Borghetti; Ludovica Pegurri; Federica Saiani; Luigi Spiazzi; Giulia Tesini; Chiara Uccelli; Luca Triggiani; Stefano Maria Magrini
Journal:  J Neurooncol       Date:  2016-03-30       Impact factor: 4.130

Review 8.  Investigation of cognitive impairments in people with brain tumors.

Authors:  Anna Rita Giovagnoli
Journal:  J Neurooncol       Date:  2012-03-06       Impact factor: 4.130

9.  Employment following chemoradiotherapy in glioblastoma: a prospective case series.

Authors:  Cecelia Gzell; H Wheeler; L Guo; M Kastelan; M Back
Journal:  J Cancer Surviv       Date:  2013-11-09       Impact factor: 4.442

10.  Neurocognitive training in patients with high-grade glioma: a pilot study.

Authors:  Marco Ronald Hassler; Katarzyna Elandt; Matthias Preusser; Johann Lehrner; Petra Binder; Karin Dieckmann; Andrea Rottenfusser; Christine Marosi
Journal:  J Neurooncol       Date:  2009-09-10       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.